Ceftriaxone and Sulbactam Injection

CeftoQub S-375: The Advanced Pediatric Shield Against Resistant Bacterial Infections

In pediatric healthcare, treating moderate to severe bacterial infections requires a balance of high-potency action and specialized safety. CeftoQub S-375 (Ceftriaxone & Sulbactam Injection 375mg) is a professional-grade, dual-action antibiotic engineered to overcome bacterial resistance in children. By combining a trusted third-generation cephalosporin with a resistance-breaking inhibitor, CeftoQub S-375 ensures clinical success even when standard antibiotics fail.

Produced by Cubic Lifesciences, a leader in the ethical pharmaceutical division, this 375mg injection is manufactured in WHO-GMP certified facilities. It serves as a vital clinical tool for pediatricians managing acute respiratory, abdominal, and systemic infections, ensuring rapid recovery and long-term wellness for young patients.

Product Overview: What is CeftoQub S-375?

CeftoQub S-375 is a sterile dry powder for injection featuring a medically optimized ratio of Ceftriaxone (250mg) and Sulbactam (125mg). This 375mg strength is specifically calibrated for pediatric dosing. While many bacteria produce “defense enzymes” to neutralize antibiotics, the Sulbactam in this formula acts as a shield, deactivating those enzymes and allowing the Ceftriaxone to eradicate the infection with 100% effectiveness.

Each pack contains a high-purity glass vial of active powder and an ampoule of sterile water for reconstitution. Designed for Intravenous (I.V.) and Intramuscular (I.M.) use, CeftoQub S-375 bypasses the digestive tract for immediate systemic absorption, providing the rapid biological response necessary for acute pediatric care.

The Science of “Dual-Strike” Recovery: How It Works

CeftoQub S-375 utilizes a coordinated biological mechanism to protect the child’s system:

1. The Cell-Wall Disruptor (Ceftriaxone): This component inhibits bacterial cell-wall synthesis, causing the harmful bacteria to lose structural integrity and burst (lysis).
2. The Resistance Neutralizer (Sulbactam): It acts as a “Beta-lactamase inhibitor,” binding to and deactivating the enzymes bacteria use to resist treatment.
3. Broad Spectrum Reach: Together, they cover a vast array of Gram-positive and Gram-negative pathogens, making it a reliable choice for “empiric therapy” in severe childhood illnesses.

Key Benefits of CeftoQub S-375 Injection

• Overcomes Antibiotic Resistance: Specifically designed to treat pediatric infections that have become resistant to ordinary, single-agent cephalosporins.
• Rapid Fever Control: Immediate systemic delivery ensures therapeutic levels are reached in the bloodstream within minutes, leading to a faster reduction in high fever.
• Superior Tissue Penetration: Effectively reaches the lungs, middle ear, and urinary tract to clear deep-seated infections.
• Ethical Pediatric Dosing: The 375mg strength allows for precise dose calculation based on a child’s weight, minimizing systemic stress while maximizing healing.
• Clinical-Grade Purity: Manufactured under rigorous quality controls to ensure the highest stability and safety for pediatric use.

Primary Clinical Applications (Indications)

Healthcare specialists and pediatricians frequently prescribe CeftoQub S-375 for:

• Severe Respiratory Infections: Including acute pneumonia and bronchitis in children.
• Complicated Ear Infections (Otitis Media): Clearing resistant bacteria behind the eardrum.
• Urinary Tract Infections (UTIs): Managing bacterial spread in the bladder or kidneys.
• Typhoid & Enteric Fever: A trusted clinical choice for managing complicated pediatric typhoid.
• Post-Surgical Care: Preventing and treating infections following pediatric surgical procedures.
• Bone and Joint Infections: Effectively managing osteomyelitis in children.

PCD Pharma Franchise Opportunity: Partner with Cubic Lifesciences

As a high-demand pediatric critical care product, CeftoQub S-375 offers a strategic opportunity for PCD Pharma Franchise partners:

• Essential Pediatric Segment: Ceftriaxone-Sulbactam combinations are a staple in pediatric wards and clinics, ensuring consistent market demand.
• Ethical Division Branding: Benefit from the expertise, authority, and trust associated with Cubic Lifesciences’ professional standards.
• Exclusive Monopoly Rights: We provide exclusive territory rights to our franchise partners, ensuring a protected and profitable business environment.
• Complete Marketing Kit: Access professional visual aids, product samples, and clinical literature to effectively build trust with pediatricians.

Frequently Asked Questions 

1. What is CeftoQub S-375 used for?
   It is used to treat serious bacterial infections in children, including those affecting the lungs, ears, stomach, and urinary tract, especially when the bacteria are resistant to standard antibiotics.

2. Why is “Sulbactam” added to the Ceftriaxone?
   Some bacteria produce enzymes that destroy regular antibiotics. Sulbactam kills those enzymes, acting as a shield so the Ceftriaxone can work perfectly to kill the bacteria.

3. How is the injection administered to a child?
   It must be administered by a qualified doctor or nurse as a Deep Intramuscular (I.M.) injection or a Slow Intravenous (I.V.) infusion after being mixed with sterile water.

4. How soon will my child start feeling better?
   Because it enters the blood directly, it starts working instantly. Most children show significant improvement in fever and symptoms within 24 to 48 hours.

5. Why is it a “powder” in the vial?
   Antibiotics of this class are most stable in powder form. Mixing it with sterile water just before use ensures your child gets the medicine at 100% clinical strength.

6. Is it safe for children with a history of allergies?
   Always inform your doctor if the child has a history of Penicillin allergy. People with Penicillin allergies may have a “cross-sensitivity” to the ingredients in CeftoQub S-375.

7. Are there any common side effects?
   Some localized pain at the injection site may occur. Occasionally, a child might experience mild diarrhea. Consult your pediatrician if a severe rash or stomach pain develops.

8. Can I stop the treatment once the fever is gone?
   No. You must complete the full course prescribed by the doctor. Stopping early allows “superbugs” to survive, which are much harder to treat in the future.